Dr. Kobe Reynders, Radiotherapie-Oncologie SRL
Dr. Kobe Reynders, Radiotherapie-Oncologie reported total assets of 246,938 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 May 2026).
The score of Dr. Kobe Reynders, Radiotherapie-Oncologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Kobe Reynders, Radiotherapie-Oncologie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 May 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
Dr. Kobe Reynders, Radiotherapie-Oncologie's financial analysis
- Solvency81.7%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Kobe Reynders, Radiotherapie-Oncologie
1 active director(s) in the register.
Dr. Kobe Reynders, Radiotherapie-Oncologie's shareholders and holdings →Dr. Kobe Reynders, Radiotherapie-Oncologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1007.472.781
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:1007472781 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Mar 2024
- Registered office
- 3110 Rotselaar
- Latest accounts
- 2025 · filed on 29 May 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Kobe Reynders, Radiotherapie-Oncologie (SRL) has been based in Rotselaar since 2024, active in: medical specialists activities. For 2025, it reports a net profit of 135,860 € and equity of 201,737 €; its revenue is not published. Its solvency stands at 81.7%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Kobe Reynders, Radiotherapie-Oncologie
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about Dr. Kobe Reynders, Radiotherapie-Oncologie
What is the revenue of Dr. Kobe Reynders, Radiotherapie-Oncologie?
Dr. Kobe Reynders, Radiotherapie-Oncologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Kobe Reynders, Radiotherapie-Oncologie?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. Kobe Reynders, Radiotherapie-Oncologie. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE1007472781. Its company number (CBE) is 1007.472.781.
Where is the registered office of Dr. Kobe Reynders, Radiotherapie-Oncologie?
According to the CBE register, the registered office of Dr. Kobe Reynders, Radiotherapie-Oncologie is in 3110 Rotselaar.
What is the equity of Dr. Kobe Reynders, Radiotherapie-Oncologie?
At the close of the 2025 financial year, the equity of Dr. Kobe Reynders, Radiotherapie-Oncologie amounts to 201,737 €, a solvency of 81.7% of total assets.
Who manages Dr. Kobe Reynders, Radiotherapie-Oncologie?
The register lists 1 active mandates at Dr. Kobe Reynders, Radiotherapie-Oncologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Kobe Reynders, Radiotherapie-Oncologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →